Req. No. 1362 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 58th Legislature (2021)
SENATE BILL 778 By: Daniels
AS INTRODUCED
An Act relating to abortion; creating the Oklahoma
Abortion-Inducing Drug Risk Protoc ol Act; defining
terms; limiting provision of abort ion-inducing drugs
to certain practitioners and procedures; prohibiting
provision through certain methods; requiring certain
examination; stating criteria of examination;
providing for complication managem ent; requiring
scheduling and certain efforts of fo llow-up visit;
prohibiting provision of abortion-inducing drugs in
certain locations; requiring informed consent within
certain time period except under specified
conditions; directing use of certain form; stating
criteria of valid form; stating additional criteria;
requiring State Department of Health to publish and
update certain materials; requiring qualified
physician to provide certain information; requiring
completion and submission of certain report; stating
required inclusions and exclusions of repo rt;
requiring certain reporting of adverse event; stating
criteria of report; requiring Department to prepare
and submit certain report; deeming reports public
records; prohibiting certain actions relating to
identity of woman; directing reports to be made
available to certain entities; requiring Department
to communicate reporting requirements; specifying
additional reporting requirements; requiring
Department to create and distribute certain forms;
providing criminal penalties; providing for certain
civil remedies, disciplinary sanctions and injunctive
relief; specifying certain judicial procedures;
providing certain construction and intent;
authorizing certain intervention; providing
severability; providi ng for codification; and
providing an effective dat e.
Req. No. 1362 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1-756.1 of Title 63, unless
there is created a duplication in numbering, re ads as follows:
This act shall be known and may be ci ted as the “Oklahoma
Abortion-Inducing Drug Risk Protocol Act”.
SECTION 2. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1 -756.2 of Title 63, unless
there is created a duplication in numbering, reads as follo ws:
As used in this act:
1. “Abortion” means the act of using or prescribing any
instrument, medicine, drug or any other substance, device or means
with the intent to terminate the pregnancy o f a woman known to be
pregnant, with knowledge that the termina tion by those means will
with reasonable likelihood cause the death of the unborn child.
Such use, prescription or means is not an abortion i f done with the
intent to:
a. save the life or pres erve the health of the unborn
child,
b. remove a dead unborn ch ild caused by spontaneous
abortion, accidental trauma or a criminal assault on
the pregnant woman or her unborn child,
c. remove an ectopic pr egnancy, or
Req. No. 1362 Page 3 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
d. treat a maternal disease or illness for which the
prescribed drug is indicated;
2. “Abortion-inducing drug” means a medicine, drug or any othe r
substance prescribed or dispensed with the intent of terminating the
pregnancy of a woman known to be pregnant, with knowledge that the
termination will with reasonable likelihood cause the death of the
unborn child. This includes the off-label use of drugs known to
have abortion-inducing properties, which are prescribed specifically
with the intent of causing an abortion, such as mifepristone
(Mifeprex), misoprostol (Cytotec) and methotrexate. This definition
does not apply to drugs that may be known t o cause an abortion, but
which are prescribed for other medical indications , such as
chemotherapeutic agents and diagnostic drugs. The use of such drugs
to induce abortion is also known as “medical”, “medication”, “RU–
486”, “chemical”, “Mifeprex regimen” or “drug-induced” abortion;
3. “Adverse Event”, according to the Food and Drug
Administration, means any untoward medical occurrence associated
with the use of a drug in humans, whether or not considered drug -
related. It does not include an adverse event or suspected adverse
reaction that, had it occurred in a more severe form, might have
caused death;
4. “Associated physician” means a person licens ed to practice
medicine in the state including medical doctors and doctors of
osteopathy, that has entered into an associated physician agreement;
Req. No. 1362 Page 4 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
5. “Complication” means any adverse physical or psycholog ical
condition arising from the performance of an a bortion which
includes, but is not limited to , uterine perforation, cervical
perforation, infection, heavy or uncontrolled bleeding, hemorrhage,
blood clots resulting in pulmonary embolism or deep vein thr ombosis,
failure to actually terminate the pregnanc y, incomplete abortion
(retained tissue), pelv ic inflammatory disease, endometritis, missed
ectopic pregnancy, cardiac arrest, respiratory arrest, renal
failure, metabolic disorder, shock, embolism, coma, placenta previa
in subsequent pregnancies, preterm delivery in subsequent
pregnancies, free fluid in the abdomen, hemolytic reaction due to
the administration of ABO-incompatible blood or blood products,
adverse reactions to anesthesia and other drugs, sub sequent
development of breast cancer, psychological complications such as
depression, suicidal id eation, anxiety, sleeping disorders, death
and any other adverse event as defined by the Food and Drug
Administration criteria provided in the Medwatch Reporti ng System;
6. “Gestational age” means the time that has elapsed since the
first day of the woman’s last menstrual period, also known as “last
menstrual period” or “LMP”;
7. “Hospital” means an institution providing medical and
surgical treatment and nurs ing care for sick or injured people, or
institutions defined under Section 1-701 of Title 63 of the Oklahoma
Statutes;
Req. No. 1362 Page 5 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
8. “Physician” means any person licen sed to practice medicine
in this state. The term includes medical doctors and doctors of
osteopathy;
9. “Pregnant” or “pregnancy” means that female reproductive
condition of having an unbor n child in the mother ’s uterus;
10. “Provide” or “provision” means, when used regarding
abortion-inducing drugs, any act of giving, selling, dispensing,
administering, transferring possession to or otherwise provid ing or
prescribing an abortion -inducing drug;
11. “Qualified physician” means a physician licensed in thi s
state who has the ability to:
a. identify and document a viable intrauterine pregnancy,
b. assess the gestational age of pregnancy and to inform
the patient of gestational age -specific risks,
c. diagnose ectopic pregnancy,
d. determine blood type and adm inister RhoGAM if a woman
is Rh negative,
e. assess for signs of domestic abuse, reproductive
control, human trafficking and other signals of
coerced abortion,
f. provide surgical interventi on or has entered into a
contract with another qualified physician to provide
surgical intervention, and
Req. No. 1362 Page 6 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
g. supervise and bear legal responsibility for any agent,
employee or contractor who is participating in any
part of procedure including, but not limited to, pre-
procedure evaluation and care;
12. “Reasonable medical judgement” means a medical judgment
that would be made by a reasonably prudent physician knowledge able
about the case and the treatment possibilities with respect to the
medical conditions involved; and
13. “Unborn child” means an individual organism of the species
homo sapiens, beginning at fertilization, until the point of being
born-alive as defined in Title 1 U.S.C., Section 8(b).
SECTION 3. NEW LAW A new sectio n of law to be codified
in the Oklahoma Statutes as Section 1 -756.3 of Title 63, unless
there is created a duplication in numbering, reads as follows:
Abortion-inducing drugs shall only be provided by a qualified
physician following procedures laid out in this act. It shall be
unlawful for any manufacturer, supplier, phy sician, qualified
physician or any other person to provide any abortion -inducing drug
via courier, delivery or mail service.
SECTION 4. NEW LAW A new section of l aw to be codified
in the Oklahoma Statutes as Section 1 -756.4 of Title 63, unless
there is created a duplication in numbering, reads as follows:
Req. No. 1362 Page 7 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
A. The qualified physician providing an abortion -inducing drug
shall examine the woman in person, and prior to providing an
abortion-inducing drug, shall:
1. Independently verify that a pregnancy exists ;
2. Determine the woman’s blood type, and if she is Rh negative,
be able to and offer to administer RhoGAM at the time of the
abortion;
3. Inform the patient that she may see the remain s or her
unborn child in the process of comp leting the abortion; and
4. Document, in the woman ’s medical chart, the gestational age
and intrauterine location of the pregnancy, and whe ther she received
treatment for Rh negativity, as diagnosed by the most accurate
standard of medical care.
B. A qualified physician providing an abortion -inducing drug
shall be credentialed and competent to handle c omplication
management including emergency transfer, or shall have a signed
contract with an associated physici an who is credentialed to handle
complications and be able to produce that signed contract on demand
by the pregnant woman or by the State Department of Health. Every
pregnant woman to whom a qualified physician provides any abortion -
inducing drug shall b e given the name and phone number of the
associated physician.
C. The qualified physician providing any abortion -inducing drug
or an agent of the qualified physician shall schedule a f ollow-up
Req. No. 1362 Page 8 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
visit for the woman at approximately seven (7) to fourteen (14 ) days
after administration of the abortion -inducing drug to confirm that
the pregnancy is completely terminated and to assess the degree of
bleeding. The qualified physician shall mak e all reasonable efforts
to ensure that the woman returns for the sched uled appointment. A
brief description of th e efforts made to comply with this subsection
including the date, time and identification by name of the person
making such efforts, shall b e included in the woman’s medical
record.
SECTION 5. NEW LAW A new section of law to be cod ified
in the Oklahoma Statutes as Section 1 -756.5 of Title 63, unless
there is created a duplication i n numbering, reads as follows:
Notwithstanding any other provision of this act or the laws of
this state, abortion-inducing drugs shall not be provided in any
school facility or on state grounds including, but not limited to,
elementary, secondary and institutions of higher education in this
state.
SECTION 6. NEW LAW A new section of law t o be codified
in the Oklahoma Statutes as Se ction 1-756.6 of Title 63, unless
there is created a duplication in numbering, reads as follows:
A. No abortion-inducing drug shall be provi ded without the
informed consent of the pregnant woman as described in this section
to whom the abortion -inducing drug is provided.
Req. No. 1362 Page 9 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. Informed consent to a chemical abortion shall be obtained at
least seventy-two (72) hours before the abortion -inducing drug is
provided to the pregnant woman, except if in reasonable medical
judgment, compliance with this subsection wo uld pose a greater risk
of:
1. The death of the pregnant woman; or
2. The substantial and irreversibl e physical impairment of a
major bodily function not including psychological or emotional
conditions, of the pregnant woman.
C. A form created by the State Department of Health shall be
used by a qualified physician to obtain the consent required prior
to providing an abortion -inducing drug.
D. A consent form is not valid and consent is not sufficient,
unless:
1. The patient initials each entry, list, description or
declaration required to be on the consent form as detailed in
paragraphs 1 through 6 of subsection E of this section;
2. The patient signs the “consent statement” described in
paragraph 11 of subsection E of this section; and
3. The qualified physician signs the “qualified physician
declaration” described in paragraph 12 of subsection E of this
section.
E. The consent form shall include, but is not limited to, the
following:
Req. No. 1362 Page 10 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1. The probable gestational age of the unborn child as
determined by both patient history and by ultrasound results used to
confirm gestational age;
2. A detailed description of the steps to complete t he chemical
abortion;
3. A detailed list of the risks related to the spec ific
abortion-inducing drug or drugs to be u sed including, but not
limited to, hemorrhaging, failure to remove all tissue of the unborn
child which may require an additional procedure , sepsis, sterility
and possible continuation of pregnancy;
4. Information about Rh incompatibility including that if she
has an Rh-negative blood type, she should receive an injection of Rh
immunoglobulin at the time of the abortion to prevent Rh
incompatibility in future pregnancies;
5. That the risks of complications from a chemical abortion
including incomplete abor tion, increase with advancing gestational
age;
6. That it may be possible to reverse the effects of th e
chemical abortion should she chan ge her mind, but that time is of
the essence;
7. That she may see the rem ains of her unborn child in the
process of completing the abortion;
Req. No. 1362 Page 11 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
8. That initial studies suggest that children born after
reversing the effects of Mifeprex/mifepristone have no greater risk
of birth defects than the general population;
9. That initial studies suggest there is no increased risk of
maternal mortality a fter reversing the effects of
Mifeprex/mifepristone;
10. That information on an d assistance with reversing the
effects of abortion-inducing drugs are available in the state -
prepared materials;
11. An “acknowledgment of risks a nd consent statement ” which
shall be signed by the patient. The statement shall include, but is
not limited to, the following declarations, which shall be
individually initialed by the patient:
a. that the patient understands that the abortion -
inducing drug regimen or procedure is in tended to end
her pregnancy and will result in the death of her
unborn child,
b. that the patient is not being forced to have an
abortion, that she has the choice not to have the
abortion and that she may withdraw her consent to the
abortion-inducing drug regimen even after she has
begun the abortion-inducing drug regimen ,
Req. No. 1362 Page 12 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
c. that the patient understands that the chemical
abortion regimen or procedure to be used has specific
risks and may result in specific complications ,
d. that the patient has been given the opportunity to ask
questions about her pregnancy, the development of her
unborn child, alternatives to abortion, the abortion -
inducing drug or drugs to be used and the risks and
complications inherent to the abortion -inducing drug
or drugs to be used,
e. that she was specifically told that “Information on
the potential ability of qualified medical
professionals to reverse the eff ects of an abortion
obtained through the use of aborti on-inducing drugs is
available at www.aborti onpillreversal.com, or you can
contact (877) 558-0333 for assistance in locating a
medical professional tha t can aide in the reversal of
an abortion.”,
f. that she has been provided access to state -prepared,
printed materials on informed consent for aborti on and
the state-prepared and maintained website on informed
consent for abortion ,
g. if applicable, that s he has been given the name and
phone number of the associated physician who has
agreed to provide medical care and treatment in the
Req. No. 1362 Page 13 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
event of complications associated with the a bortion-
inducing drug regimen or procedure ,
h. that the qualified physician will schedule an in-
person follow-up visit for the pati ent at
approximately seven (7) to fourteen (14) days a fter
providing the abortion-inducing drug or drugs to
confirm that the pregnancy is completely terminated
and to assess the degree of bleeding and othe r
complications, and
i. that the patient has receiv ed or been given sufficient
information to give her in formed consent to the
abortion-inducing drug regimen or procedure , and
j. that the patient has a private right of action to sue
the qualified physician under the laws of this state
if she feels that she has been coerced or misled prior
to obtaining an abor tion, and how to access state
resources regarding her legal right to ob tain relief;
and
12. A “qualified physician declaration ”, which shall be signed
by the qualified physician, stating that the quali fied physician has
explained the abortion -inducing drug or drugs to be used, has
provided all of the information required in subsection E of this
section, and has answered all of the woman ’s questions.
Req. No. 1362 Page 14 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SECTION 7. NEW LAW A new secti on of law to be codified
in the Oklahoma Statutes as S ection 1-756.7 of Title 63, unless
there is created a duplication in nu mbering, reads as follows:
A. The State Department of Health shall cause to be published
in the state-prepared, printed materials on informed consent for
abortion the state-prepared and maintained website on informed
consent for abortion the following statement:
“Information on the potential ability of qualified me dical
professionals to reverse the effects of an abortion obtained thr ough
the use of abortion-inducing drugs is available a t
www.abortionpillreversal.com, or you can c ontact (877) 558-0333 for
assistance in locating a medical professional that can aide in the
reversal of an abortion.”
B. On an annual basis, the Department shall review and update,
if necessary, the statement r equired in subsection A of this
Section.
C. As part of the informed consent counseling required in
Section 5 of this act, the qualified physician shall inform the
pregnant woman about abortion pill rev ersal and provide her with the
state-prepared materials and website link as proscribed by Section 6
of this act.
SECTION 8. NEW LAW A new section of law to be cod ified
in the Oklahoma Statutes as Section 1 -756.8 of Title 63, unless
there is created a duplication in numbering, reads as follows:
Req. No. 1362 Page 15 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
A. For the purpose of promoting ma ternal health and adding to
the sum of medical and public health knowledge through the
compilation of relev ant data, a report of each drug -induced abortion
performed shall be made to the State Department of Healt h on forms
prescribed by it. The reports sh all be completed by the hospital or
other licensed facility in which the abortion -inducing drug was
given, sold, dispensed, administered or otherwise provided or
prescribed; signed by the qualified physician who gave, sold,
dispensed, administered or otherwise provided or prescribed the
abortion-inducing drug; and transmitted to the Department within
fifteen (15) days after each reporting month.
B. Each report shall include, at minimum, the following
information:
1. Identification of the qualified physic ian who provided the
abortion-inducing drug;
2. Whether the chemical abortion was completed at the hospital
or licensed facility in which the abortion -inducing drug was
provided or at an alternative location;
3. The referring physician, agency or service, if any;
4. The pregnant woman’s county, state and country of residence;
5. The pregnant woman’s age and race;
6. The number of previous pregnancies, numbe r of live births
and number of previous abortions of the pregnant woman;
Req. No. 1362 Page 16 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
7. The probable gestati onal age of the unborn child as
determined by both patient history and by ultrasound results used to
confirm the gestational age. The report shall include the date of
the ultrasound and gestational age determine d on that date;
8. The abortion-inducing drug or drugs used, the date each was
provided to the pregnant woman and the reason for the abortion, if
known;
9. Preexisting medical conditions of the pregnan t woman which
would complicate her pregnancy, if any;
10. Whether the woman returned for a follo w-up examination to
determine completion of the abortion procedure and to assess
bleeding and the date and r esults of any such follow -up examination,
and what reasonable efforts were made by the qualified physici an to
encourage that she return for a follow -up examination if she did
not;
11. Whether the woman suffered any complications, and what
specific complications arose and any follow -up treatment needed;
12. The amount billed to cover the treatment for speci fic
complications including whether the tre atment was billed to
Medicaid, private insurance, private pay or other method. This
shall include charges for any physician, hospital, emergency room,
prescription or other drugs, laboratory tests and any other costs
for treatment rendered.
C. Reports required under this subsection shall not contain:
Req. No. 1362 Page 17 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1. The name of the pregnant woman;
2. Common identifiers su ch as her social security number or
driver license number; or
3. Other information or identifiers that would make it possible
to identify, in any manner or under any circumstances, a woman who
has obtained or seeks to obtain a chemical abortion.
D. If a qualified physician provides an abortion -inducing drug
to a pregnant woman for the purpose of inducing an abortion as
authorized in Sections 2 and 3 of this act, and if the qualified
physician knows that the woman who uses the abortion -inducing drug
for the purpose of inducing an abortion experiences, duri ng or after
the use of the abortion -inducing drug, an adverse event, the
qualified physician sha ll provide a written report of the adverse
event within three (3) days of the event to the Food and Drug
Administration via the Medwatch Reporting System , and to the
Department and to the State Board of Medical L icensure and
Supervision.
E. Any physician, qualified physician, associated physician or
other healthcare provider who treats a woman, either
contemporaneously to or at any time after the procedure, for an
adverse event or complication related to a chemic al abortion shall
make a report of the adver se event to the Department on forms
prescribed by it. The reports shall be completed by the hospital or
other facility in which the adverse event treatment was provided;
Req. No. 1362 Page 18 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
signed by the physician, qualified physic ian or other healthcare
provider who treated the adverse event; and transmitted to the
Department within (15) days after each reporting month.
F. The Department shall prepare a comprehensive annual
statistical report for the Legislature based upon the d ata gathered
from reports under this section. The aggregated data shall also be
made available to the public by the Department in a downloadable
format.
G. The Department shall summarize aggregate data fr om the
reports required under this act and submit the data to the Centers
for Disease Control and Prevention for the purpose of inclusion in
the annual Vital Statistics Report.
H. Reports filed pursuant t o this section shall be public
records and shall be available to the public in accordance with the
confidentiality and public records reporting l aws of this state.
Original copies of all reports filed under this subsection shall be
available to the State Board of Medical Licensure and Supervision ,
State Board of Pharmacy, state law enforcement offices and child
protective services for use in the p erformance of their official
duties.
I. Absent a valid court order or judicial subpoena, neither the
Department, any other state department, agency or office nor any
employees thereof shall compare data concerni ng abortions or
abortion complications maint ained in an electronic or other
Req. No. 1362 Page 19 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
information system file with data in any other electronic or other
information system, the comparison of which could result in
identifying, in any manner or under any circumstances , a woman
obtaining or seeking to obtain a d rug-induced abortion.
J. Statistical information that may reveal the identity of a
woman obtaining or seeking to obtain a drug-induced abortion shall
not be maintained by the Department, any other state departme nt,
agency, office or any employee or contr actor thereof.
K. Original copies of all reports filed under this section
shall be available to the Department and the State Board of Medical
Licensure and Superv ision for use in the performance of its official
duties.
L. The Department shall communicate the reporting requirements
in this section to all medical professional organizations, licensed
physicians, hospitals, emergency rooms, abortion facilities,
clinics, ambulatory surgical facilities and other healt hcare
facilities operating in this state.
M. Any physician including emergency medical personnel, who
treats a woman for complications or adverse event ari sing from an
abortion, shall file a written report as required by this section of
this act with the Department.
N. A physician filing a written r eport with the Department
after treating a woman for complications or otherwise in an
emergency capacity shall make reasonable efforts to include all of
Req. No. 1362 Page 20 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
the required information that may be obtained without viola ting the
privacy of the woman.
SECTION 9. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1 -756.9 of Title 63, unless
there is created a duplication in numbering, reads as follows:
The State Department of Health shall create and distribute the
forms required by this act within sixty (60) days after the
effective date of this act. No provision of this act requiring the
reporting of information on forms published by the Department shall
be applicable until ten (10) days after the requisite forms are
first created and distributed or until the effective date of this
act, whichever is later.
SECTION 10. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1 -756.10 of Title 63, unless
there is created a duplication in numbering, reads as follows:
A. A person who intentionally, knowingly or recklessly violates
any provision of this act is guilty of a misdemeanor.
B. A person who intentionally, knowingly or recklessly violates
any provision of this act by fraudulent use of an abortion -inducing
drug, with or without the knowledge of the pregnant woman, is guilty
of a felony.
C. No criminal penalty may be assess ed against the pregnant
woman upon whom the drug -induced abortion is attempted, induced or
performed.
Req. No. 1362 Page 21 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SECTION 11. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1-756.11 of Title 63, unless
there is created a duplication in numbering, reads as follows :
A. In addition to whatever remedies a re available under the
common or statutory law of this state, failure to comply with the
requirements of this act shall:
1. Provide a basis for a civil malpractice action for actual
and punitive damages;
2. Provide a basis for a professional disciplinary action;
3. Provide a basis for recovery for the woman ’s survivors for
the wrongful death of the woman ; and
4. Provide a basis for a cause of action for injunctiv e relief
against a person who has provided an abort ion-inducing drug in
violation of this ac t. Such an action may be maintained by:
a. a woman to whom such an abortion -inducing drug was
provided,
b. a person who is the spouse, parent or guardian of, or
a current or former licensed health care provider of,
a woman to whom an abortion-producing drug was
provided, or
c. a prosecuting attorney with appropriate jurisdiction.
The injunction shall prevent the def endant from providing
further abortion-inducing drugs in violation of this act.
Req. No. 1362 Page 22 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. No civil liability may be assessed against the pregnant
woman upon whom the drug-induced abortion is attempted, induced or
performed.
C. When requested, the court shall al low a woman to proceed
using solely her initials or a pseudonym and may close any
proceedings in the c ase and enter other protective orders to
preserve the privacy of the woman upon whom the drug -induced
abortion was attempted, induced or performed.
D. If judgment is rendered in favor of the plaintiff, th e court
shall also render judgment for reasonable attorney fees in favor of
the plaintiff against the defendant.
E. If judgment is rendered in favor of the defendant and the
court finds that the plaintiff ’s suit was frivolous and brought in
bad faith, the court may render judgment for reasonable attorn ey
fees in favor of the defendant agai nst the plaintiff.
SECTION 12. NEW LAW A new section of law to be codified
in the Oklahoma Statu tes as Section 1-756.12 of Title 63, unless
there is created a duplication in numbering, reads as follows:
A. Nothing in this act shall be construed as creating or
recognizing a right to abortion.
B. It is not the intention of this act to make lawful an
abortion that is otherwise unlawful.
C. Nothing in this act repeals, replaces or otherwise
invalidates existing federal or state laws, regulations or policies.
Req. No. 1362 Page 23 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SECTION 13. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1 -756.13 of Title 63, unless
there is created a duplication in numbering, r eads as follows:
The Legislature, by joint r esolution, may appoint one or more of
its members, who sponsored or cosponsored this act in his or her
official capacity, to intervene as a matter of right in any case in
which the constitutionality of this act is challenged.
SECTION 14. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1 -756.14 of Title 63, unless
there is created a duplication in numbering, reads as follows:
If any one or more provisions, sect ions, subsections, sentences,
clauses, phrases or words of this act or the application thereof to
any person or circumstance is found to be unconstitutional, the same
is hereby declared to be severable and the ba lance of this act shall
remain effective not withstanding such unconstitutionality. The
Legislature hereby declares that it would have passed this act, and
each provision, section, subsection, sentence, cl ause, phrase or
word thereof, irrespective of the f act that any one or more
provisions, sections, subsections, sentences, clauses, phrases or
words be declared unconstitutional.
SECTION 15. This act shall become effective November 1, 2021.
58-1-1362 DC 1/21/2021 2:13:47 PM